A multicenter retrospective study to evaluate real-world clinical outcomes in patients with metastatic renal cell carcinoma (mRCC) and brain metastasis treated with ipilimumab and nivolumab.

Landon Carter Brown,Kunal Desai,Chester Kao,Emily Noelle Kinsey,Patrick Healy,Julie Kephart,Michael R. Harrison,Sundhar Ramalingam,Andrew J. Armstrong,Daniel J. George,Allison Martin,Kimberly D Allman,Laura S. Wood,Wei Wei,Jorge A. Garcia,Timothy D. Gilligan,Shilpa Gupta,Brian I. Rini,Moshe Chaim Ornstein,Tian Zhang

A multicenter retrospective study to evaluate real-world clinical outcomes in patients with metastatic renal cell carcinoma (mRCC) and brain metastasis treated with ipilimumab and nivolumab.

2020

637Background: The combination of ipilimumab & nivolumab (I+N) followed by maintenance nivolumab has improved outcomes in patients (pts) with mRCC. Little is known about the outcomes in mRCC pts wi...

Keywords:

Oncology
Brain metastasis
Nivolumab
Pathology
Ipilimumab
Internal medicine
Renal cell carcinoma
Retrospective cohort study
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations